KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to -$719.0 million.

  • Bausch Health Companies' Cash from Financing Activities fell 280.42% to -$719.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$422.0 million, marking a year-over-year increase of 59.11%. This contributed to the annual value of -$868.0 million for FY2024, which is 158.85% down from last year.
  • As of Q3 2025, Bausch Health Companies' Cash from Financing Activities stood at -$719.0 million, which was down 300.84% from $358.0 million recorded in Q2 2025.
  • Bausch Health Companies' Cash from Financing Activities' 5-year high stood at $1.8 billion during Q3 2023, with a 5-year trough of -$1.2 billion in Q3 2021.
  • Over the past 3 years, Bausch Health Companies' median Cash from Financing Activities value was -$142.0 million (recorded in 2023), while the average stood at $9.1 million.
  • As far as peak fluctuations go, Bausch Health Companies' Cash from Financing Activities plummeted by 888.89% in 2021, and later spiked by 5,144.44% in 2023.
  • Over the past 5 years, Bausch Health Companies' Cash from Financing Activities (Quarterly) stood at $275.0 million in 2021, then crashed by 200.36% to -$276.0 million in 2022, then spiked by 71.38% to -$79.0 million in 2023, then skyrocketed by 207.59% to $85.0 million in 2024, then plummeted by 280.42% to -$719.0 million in 2025.
  • Its Cash from Financing Activities was -$719.0 million in Q3 2025, compared to $358.0 million in Q2 2025 and -$146.0 million in Q1 2025.